These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20032471)

  • 41. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.
    Chen Z; Fitzgerald RL; Averna MR; Schonfeld G
    J Biol Chem; 2000 Oct; 275(42):32807-15. PubMed ID: 10893242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects.
    Walsh MT; Di Leo E; Okur I; Tarugi P; Hussain MM
    Biochim Biophys Acta; 2016 Nov; 1861(11):1623-1633. PubMed ID: 27487388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells.
    Furukawa S; Sakata N; Ginsberg HN; Dixon JL
    J Biol Chem; 1992 Nov; 267(31):22630-8. PubMed ID: 1429611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenotypic expression of familial hypobetalipoproteinemia in three kindreds with mutations of apolipoprotein B gene.
    Tarugi P; Lonardo A; Gabelli C; Sala F; Ballarini G; Cortella I; Previato L; Bertolini S; Cordera R; Calandra S
    J Lipid Res; 2001 Oct; 42(10):1552-61. PubMed ID: 11590210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel APOB nonsense variant related to familial hypobetalipoproteinemia and hepatic steatosis: A case report and review.
    Rodríguez de Vera-Gómez P; Del Pino-Bellido P; García-González JJ; Sánchez-Jiménez F; Oliva-Rodríguez R; Arrobas-Velilla T; Martínez-Brocca MA
    J Clin Lipidol; 2022; 16(5):601-607. PubMed ID: 35918255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased production of apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7alpha-hydroxylase.
    Miyake JH; Doung XD; Strauss W; Moore GL; Castellani LW; Curtiss LK; Taylor JM; Davis RA
    J Biol Chem; 2001 Jun; 276(26):23304-11. PubMed ID: 11323427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homozygous familial hypobetalipoproteinemia. Increased LDL catabolism in hypobetalipoproteinemia due to a truncated apolipoprotein B species, apo B-87Padova.
    Gabelli C; Bilato C; Martini S; Tennyson GE; Zech LA; Corsini A; Albanese M; Brewer HB; Crepaldi G; Baggio G
    Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1189-96. PubMed ID: 8792774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations.
    Di Leo E; Eminoglu T; Magnolo L; Bolkent MG; Tümer L; Okur I; Tarugi P
    J Clin Lipidol; 2015; 9(3):400-5. PubMed ID: 26073401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic fatty acid synthesis is suppressed in mice with fatty livers due to targeted apolipoprotein B38.9 mutation.
    Lin X; Schonfeld G; Yue P; Chen Z
    Arterioscler Thromb Vasc Biol; 2002 Mar; 22(3):476-82. PubMed ID: 11884293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel APOB mutation in familial hypobetalipoproteinemia.
    Domenech M; Llano-Rivas I; Arroyo V; Ortega E
    J Clin Lipidol; 2022; 16(1):28-32. PubMed ID: 34852964
    [No Abstract]   [Full Text] [Related]  

  • 51. Apolipoprotein B sequence requirements for hepatic very low density lipoprotein assembly. Evidence that hydrophobic sequences within apolipoprotein B48 mediate lipid recruitment.
    McLeod RS; Wang Y; Wang S; Rusiñol A; Links P; Yao Z
    J Biol Chem; 1996 Aug; 271(31):18445-55. PubMed ID: 8702489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia.
    Di Filippo M; Moulin P; Roy P; Samson-Bouma ME; Collardeau-Frachon S; Chebel-Dumont S; Peretti N; Dumortier J; Zoulim F; Fontanges T; Parini R; Rigoldi M; Furlan F; Mancini G; Bonnefont-Rousselot D; Bruckert E; Schmitz J; Scoazec JY; Charrière S; Villar-Fimbel S; Gottrand F; Dubern B; Doummar D; Joly F; Liard-Meillon ME; Lachaux A; Sassolas A
    J Hepatol; 2014 Oct; 61(4):891-902. PubMed ID: 24842304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of apolipoprotein B secretion by taurocholate is controlled by the N-terminal end of the protein in rat hepatoma McArdle-RH7777 cells.
    Elzinga BM; Baller JF; Mensenkamp AR; Yao Z; Agellon LB; Kuipers F; Verkade HJ
    Biochim Biophys Acta; 2003 Dec; 1635(2-3):93-103. PubMed ID: 14729072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene.
    Elias N; Patterson BW; Schonfeld G
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1309-15. PubMed ID: 10807747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Familial hypobetalipoproteinemia secondary to a mutation in the apolipoprotein B gene].
    Blanco-Rodríguez M; Muñoz-Calvo MT; Martos-Moreno GA; Abad-Pérez E; Argente-Oliver J
    An Pediatr (Barc); 2007 May; 66(5):535-7. PubMed ID: 17517208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in human apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotes.
    Parhofer KG; Barrett PH; Aguilar-Salinas CA; Schonfeld G
    J Lipid Res; 1996 Apr; 37(4):844-52. PubMed ID: 8732784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Degradation of apolipoprotein B in cultured rat hepatocytes occurs in a post-endoplasmic reticulum compartment.
    Wang CN; Hobman TC; Brindley DN
    J Biol Chem; 1995 Oct; 270(42):24924-31. PubMed ID: 7559618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia.
    Di Costanzo A; Di Leo E; Noto D; Cefalù AB; Minicocci I; Polito L; D'Erasmo L; Cantisani V; Spina R; Tarugi P; Averna M; Arca M
    J Clin Lipidol; 2017; 11(5):1234-1242. PubMed ID: 28733173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.
    Tanoli T; Yue P; Yablonskiy D; Schonfeld G
    J Lipid Res; 2004 May; 45(5):941-7. PubMed ID: 14967820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carboxyl-terminal truncation impairs lipid recruitment by apolipoprotein B100 but does not affect secretion of the truncated apolipoprotein B-containing lipoproteins.
    McLeod RS; Zhao Y; Selby SL; Westerlund J; Yao Z
    J Biol Chem; 1994 Jan; 269(4):2852-62. PubMed ID: 8300620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.